China Health Group Limited (carrying on business in Hong Kong as CHG HS Limited) reported that its authorized share capital for ordinary shares remained at 100,000,000,000 shares, with a par value of HKD 0.1 each, totaling HKD 10,000,000,000. For its redeemable convertible cumulative preference shares, the authorized count stood at 15,000 shares with a par value of USD 0.01, amounting to USD150 (equivalent to HKD1,164). Therefore, total authorized share capital at the end of January 2026 stayed at HKD 10,000,001,164.

The report further showed no changes in the company’s issued ordinary share count. The number of issued ordinary shares closed the month at 1,339,138,191 with no treasury shares. Public float requirements, set at 25%, have been satisfied.

Regarding share options, 20,836,466 options remained outstanding under the existing share option scheme, with no new shares issued or transferred during January 2026. The company reported no warrants, convertibles, or other arrangements for issuing additional shares.